Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889980 · ClinicalTrials.gov registry record
Melanoma Molecular Profiling Analysis
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 237
- Enrollment target
NCT00889980 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 237 participants.
The verdict
NCT00889980 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 237 participants
- Enrollment target
Study Summary
There is a significant need to develop new and more effective ways to treat melanoma that will decrease patient morbidity and mortality. This protocol intends to collect and process a portion (\< 20% of any node) of lymph nodes from melanoma patients undergoing routine surgical SLN resection: the SLN(s) and 1 adjacent non-SLN(s) are planned for study. In addition, blood will be drawn at the pre study visit (serum and peripheral blood mononuclear cells) and appropriate lineage control tissue will be collected. Material only from already-indicated and planned procedures as part of standard medical care will be used. The main goal of this study will be to properly collect and process material to be analyzed and explore the molecular features melanoma biological samples.
Interventions
- OTHER Biospecimen banking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2008-05 |
| Est. Completion | 2019-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00889980
The ClinicalTrials.gov registry entry for NCT00889980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biospecimen banking is the first listed.
NCT00889980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00889980 about?
NCT00889980 is a clinical study titled "Melanoma Molecular Profiling Analysis". There is a significant need to develop new and more effective ways to treat melanoma that will decrease patient morbidity and mortality. This protocol intends to collect and process a portion (\< 20% of any node) of lymph nodes from melanoma patients undergoing routine surgical SLN resection: the SL...
What is the current status of trial NCT00889980?
This trial is currently completed. The enrollment target is 237 participants. The study started on 2008-05. Estimated completion is 2019-07-22.
What interventions are being tested in trial NCT00889980?
The interventions under investigation include: Biospecimen banking (OTHER).
Who is sponsoring clinical trial NCT00889980?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.